INS and type 1 diabetes mellitus: As research has shown that the alpha cell population remains preserved in both early and late stages of autoimmune diabetes, targeting alpha cells during the early stages of T1D appears to reprogram the alpha cells to cells that produce insulin so that these cells proliferate and can potentially secondarily reduce beta cell dysfunction [75].